The FDA has approved 2 new treatments for HIV: a once-daily fixed-dose combination tablet of doravirine, lamivudine, and tenofovir disoproxil fumarate; and doravirine, a new NNRTI to be administered in combination with other antiretroviral medicines.
A new study by St. Jude Children’s Research Hospital reported that gamma delta (γδ) T cells play a key role in protecting infants from flu complications.
The National Emerging Infectious Disease Laboratories at Boston University have the latest equipment, security redundancies, and airtight procedures and protocols. Yet, as they begin work on Ebola and Marburg, they cannot eliminate the risk of human error.
A new analysis from the CDC shows steep and sustained increases in STDs in recent years.
The CDC has announced an investigation of a multistate outbreak of Salmonella I 4,[5],12:i:- infections that have been linked with kosher chicken.
A social media campaign initiated in Russia may be sowing the seeds of debate surrounding vaccine safety, causing new outbreaks of measles globally.
West Virginia’s Bureau for Public Health has requested the assistance from the CDC to contain the statewide hepatitis A outbreak.
Additional evidence supports the use of oritavancin as a cost-saving outpatient treatment for acute bacterial skin and skin structure infections (ABSSTIs) in patients who would otherwise be admitted to the hospital for therapy.
A new analysis details the potential clinical and economic benefits of implementing antimicrobial stewardship programs in hemodialysis facilities.
A universal flu vaccine candidate elicits protective response in mice against multiple strains of the virus.
A sputum molecular testing algorithm accurately identified TB and was easily implemented in a center in San Francisco.
The FDA has approved eravacycline (XERAVA) for the treatment of complicated intra-abdominal infections.
Two public health experts discuss the recent rapid increase in incidence of infectious diseases that has been linked with injection drug use.
Can we find an alternative for chlorhexidine gluconate?
In a wounded mouse model concurrently infected with influenza A, investigators observed that the innate immune system prioritized responding to the lung infection, delaying wound healing.
New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
The Democratic of the Congo Ministry of Health has authorized the use of 5 experimental Ebola treatments as more than 100 cases of Ebola are reported.
A relatively rare event, an outbreak can be deadly for sick patients and water sources are often to blame.
Since 2006, the number of reported US listeriosis outbreaks associated with cheese made under unsanitary conditions has increased.
A new analysis by CDC investigators found that nearly 1 in 400 children aged
The FDA has added Lassa fever, chikungunya virus disease, rabies, and cryptococcal meningitis to the tropical disease Priority Review Voucher Program.
Health care providers, especially those practicing in the southern United States, should consider angiostrongyliasis in patients with eosinophilic meningitis.
A new review examines previous studies and concludes that healthcare professionals could benefit from sensitivity training when dealing with patients who have HAIs.
The incidence of Neisseria meningitidis serogroup W is rising in Georgia.
The results are significant given the ongoing debate regarding the role of contact precautions for the gram-positive bacteria.
We’ve rounded up the Salmonella outbreaks that have been declared by the US Centers for Disease Prevention and Control so far this summer.
Closing treatment gaps is critical to ending the HIV epidemic in the United States.
A new study reveals that the quadrivalent HPV catch-up vaccine was most effective against cancer risk in women who received the first dose between the ages of 14 and 20 years.
